IL123860A0 - Phenoxymethyl piperidine derivatives - Google Patents

Phenoxymethyl piperidine derivatives

Info

Publication number
IL123860A0
IL123860A0 IL12386098A IL12386098A IL123860A0 IL 123860 A0 IL123860 A0 IL 123860A0 IL 12386098 A IL12386098 A IL 12386098A IL 12386098 A IL12386098 A IL 12386098A IL 123860 A0 IL123860 A0 IL 123860A0
Authority
IL
Israel
Prior art keywords
piperidine derivatives
phenoxymethyl
phenoxymethyl piperidine
derivatives
piperidine
Prior art date
Application number
IL12386098A
Other languages
English (en)
Inventor
Lee Allen Flippin
Xiao-Fa Lin
David Garrett Loughhead
Robert James Weikert
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL123860A0 publication Critical patent/IL123860A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL12386098A 1997-04-03 1998-03-27 Phenoxymethyl piperidine derivatives IL123860A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4268197P 1997-04-03 1997-04-03
US6975597P 1997-12-16 1997-12-16

Publications (1)

Publication Number Publication Date
IL123860A0 true IL123860A0 (en) 1998-10-30

Family

ID=26719512

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12386098A IL123860A0 (en) 1997-04-03 1998-03-27 Phenoxymethyl piperidine derivatives

Country Status (13)

Country Link
EP (1) EP0869119A1 (fr)
JP (1) JP2938432B2 (fr)
KR (1) KR100257958B1 (fr)
CN (1) CN1194977A (fr)
AU (1) AU743476B2 (fr)
CA (1) CA2232147A1 (fr)
CZ (1) CZ98898A3 (fr)
HU (1) HUP9800707A3 (fr)
IL (1) IL123860A0 (fr)
MA (1) MA26480A1 (fr)
NO (1) NO310354B1 (fr)
NZ (1) NZ330017A (fr)
PL (1) PL325687A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9808015D0 (en) * 1998-04-15 1998-06-17 United Medical And Dental Scho Protection of the nervous system from the effects of inflammatory disease
US6420354B1 (en) 1998-06-08 2002-07-16 Advanced Medicine, Inc. Sodium channel drugs and uses
DE19907385A1 (de) * 1999-02-20 2000-08-24 Boehringer Ingelheim Pharma Neue substituierte 3-Phenoxy- und 3-Phenylalkyloxy-2-phenyl-propylamine
AU3676100A (en) 1999-04-09 2000-11-14 Mochida Pharmaceutical Co., Ltd. Remedies for neuropathic pain
US6479498B1 (en) 1999-06-04 2002-11-12 Theravance, Inc. Sodium channel drugs and uses
US6756400B2 (en) 2000-08-31 2004-06-29 Theravance, Inc. Sodium channel modulators
US6646012B2 (en) 2001-01-16 2003-11-11 Theravance, Inc. Sodium channel modulators
JPWO2004011430A1 (ja) * 2002-07-25 2005-11-24 アステラス製薬株式会社 ナトリウムチャネル阻害剤
GB0218827D0 (en) * 2002-08-13 2002-09-18 Syngenix Ltd Anaesthetic compounds and conjugates thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1203149A (en) * 1968-06-10 1970-08-26 Ici Ltd Piperidine derivatives
MX9100517A (es) * 1990-08-06 1992-04-01 Smith Kline French Lab Compuestos
FR2667317B1 (fr) * 1990-10-02 1992-12-04 Synthelabo Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.
GB9226111D0 (en) * 1992-12-15 1993-02-10 Smithkline Beecham Plc Madicaments

Also Published As

Publication number Publication date
HUP9800707A2 (hu) 1999-05-28
JPH10287649A (ja) 1998-10-27
NZ330017A (en) 1999-04-29
CZ98898A3 (cs) 1998-10-14
NO981495D0 (no) 1998-04-02
JP2938432B2 (ja) 1999-08-23
EP0869119A1 (fr) 1998-10-07
HU9800707D0 (en) 1998-05-28
NO981495L (no) 1998-10-05
KR100257958B1 (ko) 2000-07-01
HUP9800707A3 (en) 1999-06-28
MA26480A1 (fr) 2004-12-20
KR19980081053A (ko) 1998-11-25
AU743476B2 (en) 2002-01-24
AU5937998A (en) 1998-10-08
NO310354B1 (no) 2001-06-25
PL325687A1 (en) 1998-10-12
CN1194977A (zh) 1998-10-07
CA2232147A1 (fr) 1998-10-03

Similar Documents

Publication Publication Date Title
ZA9811345B (en) Piperidine derivatives
ZA962200B (en) Piperidine derivatives
EG23756A (en) D-proline derivatives
PL334847A1 (en) Substituted 3-heterocyclyl-benzoyl derivatives
AU2942000A (en) Novel piperidine derivatives
HU9701194D0 (en) 4-hydroxy-piperidine derivatives
ZA952431B (en) New piperidine derivatives
HU9801168D0 (en) Triazinylaminostilbene derivatives
ZA992191B (en) Piperidine derivatives.
HU9800707D0 (en) Phenoxymethyl piperidine derivatives
ZA200101830B (en) Piperidine derivatives.
ZA979781B (en) Piperidine derivatives.
SG71062A1 (en) 4-Hydroxy piperidine derivatives
ZA972329B (en) Piperidine derivatives
AU7557000A (en) Piperidine derivatives
AU3836600A (en) N-substituted piperidine derivatives
AU5679398A (en) Piperidine derivatives
ZA97329B (en) Piperidine or tetrahydropyridine derivatives
AU9462098A (en) Piperidine derivatives
ZA982618B (en) Phenoxymethyl piperidines derivatives
IL135195A0 (en) Substituted piperidine derivatives
HK1028765A (en) Antipsychotic substituted piperidine derivatives
IL120313A0 (en) Piperidine derivatives as neurokinin antagonists
ZA989889B (en) D-proline derivatives
HU9702315D0 (en) 4-hydroxy-piperidine derivatives